ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет Архив журнала 2001 год № 3

Резистентность к тиреоидным гормонам

О. Баккер, В.М. Версинга Амстердам (Нидерланды)
Division of Endocrinology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands Thyroid international 3 - 2001
Русский перевод к.м.н. Фадеева В.В. (примечания переводчика отмечены *)

ЛИТЕРАТУРА

1. Abel E.D., Kaulbach H.C., Campos-Barros A., Ahima R.S., Boers M.E., Hashimoto K., Forrest D., Wondisford F.E. Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin. // J Clin Invest – 1999 – Vol. 103 – P. 271 – 279.
2. Adams M., Matthews C., Collingwood T.N., Tone Y., Beck P.P, Chatterjee K.K. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. // J Clin Invest – 1994 – Vol. 94 – P. 506 – 515.
3. Asteria C., Rajanayagam O., Collingwood T.N., Persani L., Romoli R., Mannavola D., Zamperini P., Buzi F., Ciralli F., Chatterjee V.K., Beck-Peccoz P.  Prenatal diagnosis of thyroid hormone resistance. // J Clin Endocrinol Metab – 1999 – Vol. 84 – P. 405 – 410.
4. Bantle J.P., Seeling S., Mariash C.N., Ulstrom R.A., Oppenheimer J.H. Resistance to thyroid hormones. A disorder frequently confused with Graves' disease. // Arch Intern Med – 1982 – Vol. 142 – P. 1867 – 1871.
5. Beck-Peccoz P., Chatterjee V.K. The variable clinical phenotype in thyroid hormone resistance syndrome. // Thyroid – 1994 – Vol. 4 – P. 225 – 232.
6. Beck-Peccoz P., Persani L., Mantovani S., Cortelazzi D., Asteria C. Thyrotropin-secreting pituitary adenomas. // Metabolism – 1996 – Vol. 45 (Suppl. 9).
7. Brown N.S., Smart A., Sharma V., Brinkmeier M.L., Greenlee L., Camper S.A., Jensen D.R., Eckel R.H., Krezel W., Chambon P., Haugen B.R. Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. // J Clin Invest - 2000 – Vol. 106. – P. 73 – 79.
8. Brucker-Davis F., Skarulis M.C., Grace M.B., Benichou J., Hauser P., Wiggs E., Weintraub B.D. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. // Ann Intern Med – 1995 – Vol. 123. – P. 572 – 583.
9. Clifton-Bligh R.J., de Zegher F., Wagner R.L., Collingwood T.N., Francois I., Van Helvoirt M., Fletterick R.J., Chatterjee V.K. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. // Mol Endocrinol - 1998 –Vol. 12. – P. 609 – 621.
10. Collingwood T.N., Adams M., Tone Y., Chatterjee V.K. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. // Mol Endocrinol. – 1994 – Vol. 8. – P. 1262 – 1277.
11. Collingwood T.N., Wagner R., Matthews C.H., Clifton-Bligh R.J., Gurnell M., Rajanayagam O., Agostini M., Fletterick R.J., Beck-Peccoz P., Reinhardt W., Binder G., Ranke M.B., Hermus A., Hesch R.D., Lazarus J., Newrick P., Parfitt V., Raggatt P., de Zegher F., Chatterjee V.K. A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. // EMBO J – 1998 – Vol. 17 – P. 4760 – 4770.
12. Darendeliler F., Bas F. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone. // J Pediatr Endocrinol Metab. – 1997 – Vol. 10. – P. 535 – 538. 
13. Ercan-Fang S., Schwartz H.L., Mariash C.N., Oppenheimer J.H. Quantitative assessment of pituitary resistance to thyroid hormone from plots of the logarithm of thyrotropin versus serum free thyroxine index. // J Clin Endocrinol Metab. -  2000 – Vol. 85 – P. 2299 – 2303.
14. Forrest D., Hanebuth E., Smeyne R.J., Everds N., Stewart C.L., Wehner J.M., Curran T. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. // EMBO J – 1996 – Vol. 15 – P. 3006 – 3015.
15. Hauffa B.P., De Nayer P. Metabolic and cardiovascular responses to exogenous triiodothyronine favour nontreatment of a girl with familial receptor-positive thyroid hormone resistance. // Acta Paediatr Scand – 1990 – Vol. 79 – P. 191–195.
16. Hayashi Y., Weiss R.E., Sarne D.H., Yen P.M., Sunthornthepvarakul T., Marcocci C., Chin W.W., Refetoff S. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? // J Clin Endocrinol Metab – 1995 – Vol. 80 – P. 3246 – 3256.
17. Jones A., Austin J., Hansen N., Hoogendoorn B., Oefner P.J., Cheadle J.P., O’Donovan M.C. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. // Clinical Chemistry – 1999 - Vol. 45, N 8. – P. 1133–1140.
18. Kunitake J.M., Hartman N., Henson L.C., Lieberman J., Williams D.E., Wong M., Hershman J.M. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance. // J Clin Endocrinol Metab – 1989 – Vol. 69. – P. 461 – 466.
19. McDonald M.P., Wong R., Goldstein G., Weintraub B., Cheng S.Y., Crawley J.N. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. // Learning & Memory – 1998 – Vol. 5 – P. 289 – 301.
20. Mixson A.J., Hauser P., Tennyson G., Renault J.C., Bodenner D.L., Weintraub B.D. Differential expression of mutant and normal beta T 3 receptor alleles in kindreds with generalized resistance to thyroid hormone. // J Clin Invest -  1993 – Vol. 91. – P. 2296 – 2300.
21. Nagaya T., Jameson J.L. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. // J Biol Chem – 1993 – Vol. 268 – P. 15766 – 15771.
22. Persani L., Asteria C., Tonacchera M., Vitti P., Krishna V., Chatterjee K., Beck-Peccoz P. Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. // J Clin Endocrinol Metab – 1994 – Vol. 78 – P. 1034 – 1039.
23. Pohlenz J., Knobl D. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy. // Acta Paediatr – 1996 – Vol. 85 – P. 387 – 390.
24. Pohlenz J., Weiss R.E., Macchia P.E., Pannain S., Lau I.T., Ho H., Refetoff S. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. // J Clin Endocrinol Metab – 1999 – Vol. 84. – P. 3919 – 3928.
25. Radetti G., Persani L., Molinaro G., Mannavola D., Cortelazzi D., Chatterjee V.K., Beck-Peccoz P. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. // Thyroid -  1997 – Vol. 7. – P. 775 – 778.
26. Refetoff S., DeWind L.T., DeGroot L.J. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. // J Clin Endocrinol Metab – 1967 – Vol. 27. – P. 279 – 294.
27. Refetoff S., Weiss R.E., Usala S.J. The syndromes of resistance to thyroid hormone. // Endocr Rev – 1993 – Vol. 14. – P. 348 – 399.
28. Safer J.D., Cohen R.N., Hollenberg A.N., Wondisford F.E. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. // J Biol Chem – 1998 – Vol. 273. – P. 30175 – 30182.
29. Sakurai A., Miyamoto T., Refetoff S., DeGroot L.J. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. // Mol Endocrinol. – 1990 – Vol. 4. – P. 1988 – 1994.
30. Schwartz I.D., Bercu B.B. Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T 3 receptor. // Thyroid – 1992 – Vol. 2. – P. 15 – 19.
31. Snyder D., Sesser D., Skeels M., Nelson G., La Franchi S. Thyroid disorders in newborn infants with elevated screening T4. // Thyroid – 1997 - 7 (suppl 1) - S-29 (abstract)
32. Ueda S., Takamatsu J., Fukata S., Tanaka K., Shimizu N., Sakata S., Yamaji T., Kuma K., Ohsawa N. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone. //Thyroid – 1996 – Vol. 6. – P. 563 – 570.
33. Usala S.J., Bale A.E, Gesundheit N., Weinberger C., Lash R.W., Wondisford F.E., McBride O.W., Weintraub B.D. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. // Mol Endocrinol – 1988 – Vol. 2. – P. 1217 – 1220.
34. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. // Nature – 1995 – Vol. 378. – P. 690 – 697.
35. Weiss R.E., Marcocci C., Bruno-Bossio G., Refetoff S. Multiple genetic factors in the heterogeneity of thyroid hormone resistance.// J Clin Endocrinol Metab – 1993 – Vol. 76. – P. 257 – 259.
36. Weiss R.E., Hayashi Y., Nagaya T., Petty K.J., Murata Y., Tunca H., Seo H., Refetoff S. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. // J Clin Endocrinol Metab – 1996 – Vol. 81 – P. 4196 – 4203.
37. Weiss R.E., Stein M.A., Refetoff S. Behavioral effects of liothyronine (L-T3) in children with attention deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone. //Thyroid – 1997 – Vol. 7 – P. 389 – 393.
38. Weiss R.E., Refetoff S. Treatment of resistance to thyroid hormone - primum non nocere. // J Clin Endocrinol Metab - 1999a – Vol. 84. – P. 401 – 404.
39. Weiss R.E., Xu J., Ning G., Pohlenz J., O'Malley B.W., Refetoff S. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. // EMBO J. - 1999b – Vol. 18 – P. 1900 – 1904.
40. Weiss R.E., Refetoff S. Resistance to thyroid hormone. // Rev Endocrine Metabol Dis - 2000 – Vol. 1 – P. 97 – 108.
41. Wong R., Vasilyev V.V., Ting Y.T., Kutler D.I., Willingham M.C., Weintraub B.D., Cheng S. Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity. // Mol Med  - 1997 – Vol. 3. – P. 303 – 314.
42. Zhang J., Lazar M.A. The mechanism of action of thyroid hormones. // Ann. Rev. Physiol. - 2000 – Vol. 62. – P. 439 – 466.
43. Zhu X.G., Kaneshige M., Parlow A.F., Chen E., Hunziker R.D., McDonald M.P., Cheng S.Y. Expression of the mutant thyroid hormone receptor PV in the pituitary of transgenic mice leads to weight reduction. // Thyroid – 1999 – Vol. 9 – P. 1137 – 1145.